Board of Directors

SuperDerivatives’ board of directors combines financial expertise with technological innovation to guide the company’s strategic direction, drawing from backgrounds in banking, corporate treasury, options trading, hedge funds and venture capital.

Their educated interpretation of the financial markets identifies opportunities to increase the profitability of customers' derivatives business.

Dr. David Gershon
Chairman and Chief Executive Officer
Dr. David Gershon founded SuperDerivatives in 2000 with the aim of introducing transparency to the world of options.
read more...

Lewis Ranieri 
Lewis Ranieri is a board member and is the Chairman of the Advisory Board of SuperDerivatives. Ranieri is the originator and founder of Hyperion and Ranieri Partners Affiliated private equity fund.
read more...

Scott Shay
Scott Shay has played a very active role on the board of SuperDerivatives since the company’s inception.
read more...

Sam Somech

Executive Vice President, Head of R&D
Sam Somech is responsible for SuperDerivatives' global product development activities and has been an investor and a member of the board since 2004.
read more...

Dr. David Gershon
Chairman and Chief Executive Officer

Dr. David Gershon founded SuperDerivatives in 2000 with the aim of introducing transparency to the world of options. Since then, the company has expanded rapidly to have a strong global presence and is today recognised as the benchmark for option pricing and a market leader in derivatives technology including front end platforms, risk management systems, revaluation services and online execution utilities.

Dr. Gershon’s vision to bring transparency to the world of options has materialised with a significant part of derivatives professionals all over the world utilise SuperDerivatives platforms for their day to day activities. Furthermore, many industry observers credit SuperDerivatives for the sizable growth in the number of options users over the past couple of years and the dramatic increase in liquidity.

Prior to starting SuperDerivatives, Dr. Gershon was Global Head of FX Exotic Options for Barclays Capital, based in the bank’s London headquarters. Earlier in his career he had traded at BZW New York (later to become Barclays Capital), covering emerging markets during their most volatile periods, and at Deutsche Bank in New York. Gershon’s career on Wall Street began in 1994 in NationsBank’s mortgage department.

Dr. Gershon has a Ph.D. in theoretical physics (Superstring theory), an MBA and an M.Sc. in Finance. The combination of his academic background and rich market experience has proved fundamental in the development of the patented SuperDerivatives benchmark pricing model for options, which uniquely provides an accurate reflection of the bid and offer prices of options in the inter-bank market in all asset classes.

back to top

Lewis Ranieri  

Lewis Ranieri is a board member and is the Chairman of the Advisory Board of SuperDerivatives.

Ranieri is the originator and founder of Hyperion and Ranieri Partners Affiliated private equity fund. He has also served as Chairman of American Financial Realty Trust, Root Markets, Franklin Bank Corp, Capital Lease Funding Inc., and Computer Associates (CA) Inc.

Prior to forming Hyperion, Ranieri was Vice Chairman of Salomon Brothers Inc., and is generally considered as one of the leading players of the securitised mortgage market. He helped develop the capital markets as a source of funds for housing and commercial real estate, establishing Salomon’s leadership position in the mortgage-backed securities area. He also led the effort to obtain federal legislation to support and build the market.

Ranieri is a recipient of the lifetime achievement award given by the Fixed Income Analysts Society, and was also elected to the Housing Hall of Fame. In November 2004, BusinessWeek magazine named him one of the "greatest innovators of the past 75 years,” and in 2005 he received the Distinguished Industry Service Award by the American Securitization Forum.

Ranieri acts as a trustee or director of the Environmental Defense Fund, the Metropolitan Opera Association and the American Ballet Theatre.

back to top

Scott Shay

Scott Shay has played a very active role on the board of SuperDerivatives since the company’s inception.

Among his other endeavors, Shay serves as Chairman, as well as a founder, of Signature Bank in New York, Managing Director of Ranieri Partners LLC, and as a partner of Hyperion Partners since 1988. As part of Hyperion’s investment activities, Shay has served on the boards of many corporations.

Shay's involvement in investment banking and venture capital dates back to 1980. Prior to joining Ranieri/Hyperion, Scott was a Director and a senior member of the Mergers and Acquisitions department of Salomon Brothers.

Sam Somech
Executive Vice President, Head of R&D

Sam Somech is responsible for SuperDerivatives' global product development activities and has been an investor and a member of the board since 2004.

Somech is widely regarded as one of the world’s leading experts on middleware messaging technologies and is an experienced and successful entrepreneur. He founded Data Voice Systems, which was acquired by IBM and became the foundation of IBM’s MQSeries®.

Sam later co-founded and served as CEO of the software company Level 8, which successfully floated on NASDAQ in 1996. Level 8’s technology was acquired by Microsoft to provide the foundation for its MSMQ Messaging application. Sam was also involved in several technology companies such as Traiana, a financial technology company which was later sold to ICAP in 2007, and served as Chairman of Itemfield, which he sold in early 2007 to Informatica Corporation.

Forgotten login details? Click Here

Sign up for a Free Trial